Loading…
Loading…
EQUITY / NASDAQ · XNMS
Tevogen Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗6.98 USD · 0%
Observed: Oct 2, 2026, 7:59 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 6.98 USD · Volume 1,626
250 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -5,662,376 USD | -5,444,536 USD | — |
| Net income | -5,761,940 USD | -5,503,979 USD | — |
| Total liabilities | 13,616,501 USD | — | — |
| Total equity | -8,888,760 USD | -9,484,742 USD | — |
| Total assets | 4,727,741 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -5,761,940 USD | -11,208,195 USD | -5,446,255 USD | — | -26,275,432 USD | -5,726,812 USD | -21,597,852 USD | -5,503,979 USD |
| Operating profitIncome statement | -5,662,376 USD | -11,063,296 USD | — | — | -26,140,515 USD | -5,729,431 USD | -21,530,314 USD | -5,444,536 USD |
| Total assetsBalance sheet | 4,727,741 USD | — | — | 4,382,994 USD | 4,382,994 USD | 4,493,669 USD | — | — |
| Total equityBalance sheet | -8,888,760 USD | — | -9,842,158 USD | -8,234,726 USD | -8,234,726 USD | -7,823,896 USD | — | -9,484,742 USD |
| Total liabilitiesBalance sheet | 13,616,501 USD | — | — | 12,617,720 USD | 12,617,720 USD | 12,317,565 USD | — | — |
| Financing cash flowCash flow statement | — | 6,268,955 USD | — | — | 11,662,393 USD | — | 9,901,409 USD | — |
| Operating cash flowCash flow statement | — | -5,739,172 USD | — | — | -12,328,577 USD | — | -10,147,310 USD | — |
| Capital expendituresCash flow statement | — | — | — | — | 64,439 USD | — | — | — |
| Cash and cash equivalentsBalance sheet | — | — | — | — | 0 USD | — | — | — |
| Investing cash flowCash flow statement | — | — | — | — | -64,439 USD | — | — | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.